神経補綴の世界市場－市場規模、セグメント、展望、収益予測：タイプ別、技術別、用途別、地域別（2022年～2028年）

世界の神経補綴の市場規模は、2017年に約50億米ドル、2022年に約80億米ドルに達し、2028年には約150億米ドルに達する見込みで、予測期間中に12%のCAGRで成長すると予測されています。神経系疾患の増加は、市場の成長を促進しています。しかし、神経補綴製品の高コストが、市場の成長を阻んでいます。

当レポートでは、世界の神経補綴市場について調査分析し、主要な動向、競合情勢、市場分析など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

• 世界の神経補綴市場の成長実績と予測のハイライト
• 市場動向、課題、競合のハイライト
• 市場収益シェアのハイライト：セグメント別

第2章 市場概要と成長に影響を与える主要な動向

• 世界の神経補綴市場の分類
• 業界のバリューチェーン
• 世界の神経補綴市場における主要企業のエコシステム
• 政府の規制と開発
• 市場に影響を与える主要な促進要因と課題
• COVID-19が世界の神経補綴市場に与える影響
• 神経補綴市場の成長実績（2017年～2021年）：セグメントタイプ別
• タイプ別
• 技術別
• 用途別
• 地域別
• 全世界神経補綴市場の成長実績と予測（2017年～2028年）
• 重要ポイント

第3章 世界の市場セグメンテーション、成長実績、展望、予測：タイプ別

• 市場の定義－セグメンテーション：タイプ別
• 市場収益シェア、成長実績、展望、予測（2017年～2028年）：タイプ別
• 出力
• 入力
• 市場セグメンテーションからの重要ポイント：タイプ別

第4章 世界の市場セグメンテーション、成長実績、展望、予測：技術別

• 市場の定義－セグメンテーション：技術別
• 市場収益シェア、成長実績、展望、予測（2017年～2028年）：技術別
• 脳深部刺激
• 迷走神経刺激
• 脊髄刺激
• 仙骨神経刺激
• 市場セグメンテーションからの重要ポイント：技術別

第5章 世界の市場セグメンテーション、成長実績、展望、予測：用途別

• 市場の定義－セグメンテーション：用途別
• 市場収益シェア、成長実績、展望、予測（2017年～2028年）：用途別
• 運動神経補綴
• 生理的障害
• 認知障害
• 市場セグメンテーションからの重要なポイント：用途別

第6章 業界/競合分析－競合情勢

• 企業（競合企業）のタイプと競合シェア
• 世界の神経補綴の競合に関するポーターのファイブフォース分析
• 市場の成長に影響を与える世界の神経補綴セクターの主な開発
• 世界の神経補綴市場における主要な競合の比較（2021年）
• 世界の神経補綴市場における主要な競合の比較（2021年）：タイプ範囲別
• 世界の神経補綴市場における主要な競合の比較（2021年）：技術範囲別
• 世界の神経補綴市場における主要な競合の比較（2021年）：用途範囲別
• 世界の神経補綴市場における主要な競合の比較（2021年）：地域範囲別
• 競合情勢からの重要ポイント

第7章 主要な競合企業プロファイル（企業概要、製品オファリング、強みと弱みの分析）

• Abbott
• Boston Scientific Corporation
• Cochlear Ltd
• Cyberonics, Inc.
• LivaNova PLC
• Medtronic
• NeuroPace, Inc.
• BioRegio STERN Management GmbH
• Second Sight
• Sonova

第8章 地域分析と主要国の市場の成長実績、展望、予測

• 主要国のマクロ経済要因比較
• 世界市場の収益シェア、成長実績、展望と予測（2017年～2028年）：地域別
• 主要国の市場分析、成長実績、展望と予測
• 北米－神経補綴市場分析
• 欧州－ 神経補綴市場分析
• アジア太平洋－ 神経補綴市場分析
• ラテンアメリカ、中東、アフリカ－神経補綴市場分析

第9章 業界専門家の意見/展望

• 市場の現状と将来の展望に関する業界専門家と経営幹部の注目すべき声明/引用

第10章 アナリストの推奨

• 特定された主要な機会と機会から得られる可能性のある戦略に関するアナリストの推奨事項

第11章 付録

• 調査手法－市場規模の推定、予測、および健全性チェックのアプローチ
• サンプルディスカッションガイド

免責事項

Market Overview:

A neuroprosthetic (also called as neural prosthetic) is any device that can enhance the input or output of a neural system. The most successful neuroprosthetic devices developed to date are cochlear implants for patients with hearing impairment, and prosthetic devices for amputees. Neuroprosthetics encompass a variety of artificial devices or systems that can be used to enhance the motor, sensory, cognitive, visual, auditory, and communicative deficits that arise from acquired brain injuries.

According to Ken Research Analysis, the Global Neuroprosthetics Market was valued at ~US$ 5 billion in 2017. It is estimated to be ~US$ 8 billion in 2022 and is forecasted to reach a market size of ~US$ 15 billion, growing at a CAGR of ~12% owing to the rising demand from the manufacturing industry.

The increasing prevalence of neurological disorders is driving the growth of the market. Neuroprosthetics are used when other treatments are unable to cure a disease or condition. The adoption of neuroprosthetic technologies, such as SCS, DBS, Vagus nerve stimulation (VNS), and sacral cord stimulation, is growing in developed countries such as the US, Canada, and Australia, boosting the growth of the overall market.

The high cost of neuroprosthetic products is challenging the neuroprosthetics market growth. Cochlear implants are more expensive than hearing aids. The high cost of surgery and difficulty in maintenance is anticipated to pose a significant challenge during the forecast time. The high cost of the implants, as well as the problem of maintaining them, has hampered market growth.

The market was significantly impacted by the COVID-19 pandemic during the first half of 2020, due to a major drop in non-urgent treatments such as cochlear implant surgery around the world. With the increase in COVID-19 cases, governments around the world implemented various safety measures such as lockdowns and stringent guidelines, disrupting the international supply chain of cochlear implants.

Scope of the Report:

The Neuroprosthetics market is segmented by type, technique, application, and region. In addition, the report also covers the market size for each of the four regions' Neuroprosthetics market. The revenue used to size and forecast the market for each segment is US$ billion.

Type

Output Neural Prosthetics

Motor Prosthetics

Cognitive Prosthetics

Input Neural Prosthetics

Cochlear Implants

Bionic Eye/Retinal Implants

Technique

Deep Brain Stimulation

Vagus Nerve Stimulation

Spinal Cord Stimulation

Sacral Nerve Stimulation

Application

Motor Neural Prosthetics

Parkinson's disease

Epilepsy

Physiological Disorders

Auditory Processing Disorders

Ophthalmic Disorders

Cardiovascular Disorders

Urology Disorders

Cognitive Disorders

Alzheimer's Disease

Paralysis

Region

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Spain, Italy, Rest of Europe)

Asia Pacific (China, Japan, South Korea, India, Indonesia, Australia, Rest of Asia Pacific)

LAMEA (Latin America, Middle East, Africa)

Key Players

Abbott

Boston Scientific Corporation

Cochlear Ltd

Cyberonics, Inc.

LivaNova PLC

Medtronic

NeuroPace, Inc.

BioRegio STERN Management GmbH

Second Sight

Sonova

Key Trends by Market Segment

By Type: The input neural prosthetics segment held the largest market share in the global neuroprosthetics market in 2021, owing to the growing burden of hearing loss and advancements in technology for the development of novel devices.

The input neural prosthetics include a cochlear Implant and bionic eye/retinal Implant. These are electronic devices that can help to provide a sense of sound to a person who is profoundly deaf or severely hard of hearing.

The motor prosthetics segment held a significant share of the market owing to the rising adoption of bladder control implants and brain-computer interfaces for paraplegic and lateral sclerosis patients.

By Technique: The spinal cord stimulation segment held the largest market share in the global neuroprosthetics market in 2021, due to the rising prevalence of chronic pain among the population across the globe.

The increasing failed back syndrome, and complex regional pain syndrome are projected to increase the demand for spinal cord stimulation technology-based neuroprosthetics devices.

The recent product approvals based on spinal cord stimulation technology is likely to propel the neuroprosthetics market in the coming future. For instance, in July 2021, Nevro received FDA approval for its 10 kHz high-frequency spinal cord stimulation therapy for the treatment of chronic pain associated with Painful Diabetic Neuropathy (PDN).

By Application: The motor neural prosthetics segment held the largest market share in the global Neuroprosthetics market in 2021, owing to its rising adoption in parkinson's and epilepsy coupled with the rising prevalence of these aforementioned disorders.

Cognitive disorders segment is expected to hold the highest CAGR during the forecast period, owing to the rising incidences of Alzheimer's disease and severe depression.

The introduction of advanced implants capable of calculating limb trajectory and stimulating motor control for movements, used in the treatment of paralysis are further anticipated to augment the market growth over the forecast period.

By Region: North Americaheld the largest market share among all other regions within the global neuroprosthetics market in 2021, due to the supporting government policies to augment the growth of the region.

The large share of the region is attributed to the presence of factors, such as government & private funding and well-established healthcare facilities.

In the USA, more than a thousand people are living with spinal cord injury and half of these people cannot move from the neck which is expected to drive the treatment through neuroprosthetics.

Competitive Landscape

The Global Neuroprosthetics Market is highly competitive with ~150 players, including globally diversified players, regional players, and many country-niche players. Most of the regional players are the developers of Neuroprosthetics used in various end-user industries.

Country-niche players constitute ~25% of the total number of competitors, while regional players dominate representing ~45% of total competitors. Some of the major players in the market include Abbott, Boston Scientific Corporation, Cochlear Ltd, Cyberonics, Inc., LivaNova PLC, Medtronic, NeuroPace, Inc., BioRegio STERN Management GmbH, Second Sight, Sonova, among others.

Recent Developments Related to Major Players and Organizations

In July 2022, Sensorion declared that regulatory authorities in Australia have given their approval for the start of a Proof of Concept (POC) clinical trial of SENS-401 (Arazasetron) in patients who are scheduled for cochlear implantation.

In January 2022, TODOC, a Korean company that specializes in neural prosthesis and neuromodulation systems, announced the introduction of its artificial cochlear implant 'SULLIVAN' at the "CES 2022" in Las Vegas.

Conclusion

The Global Neuroprosthetics Market witnessed a negative impact due to COVID-19 owing to the strict regulations in several countries that temporarily halted all types of processes and shut down all the major industries. Input Neural Prosthetics, which include cochlear implants and bionic eye/retinal implants are the most common type of neuroprosthetics. Majorly, the spinal cord stimulation neuroprosthetics technique is used for treating cognitive disorders such as Alzheimer's disease and paralysis. Though the market is competitive with over ~150 participants, regional players control the dominant share in the market and country-niche players also hold a significant share.

Note: This is an On-Demand/Planned report, so the figures quoted here for market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and report delivered within a maximum of 2 working weeks.

Key Topics Covered in the Report

Snapshot of Global Neuroprosthetics Market

Industry Value Chain and Ecosystem Analysis

Market size and Segmentation of the Global Neuroprosthetics Market

Historic Growth of Overall Global Neuroprosthetics Market and Segments

Competition Scenario of the Market and Key Developments of Competitors

Porter's 5 Forces Analysis of Global Neuroprosthetics Industry

Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors

Covid-19 Impact on the Overall Global Neuroprosthetics Market

Future Market Forecast and Growth Rates of the Global Neuroprosthetics Market and Segments

Analysis of Global Neuroprosthetics Market

Major Production/Supply and Consumption/Demand Hubs within Each Region

Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments

Overview of Notable Emerging Competitor Companies within Each Region

Notable Key Players Mentioned in the Report

Abbott

Boston Scientific Corporation

Cochlear Ltd

Cyberonics, Inc.

LivaNova PLC

Medtronic

NeuroPace, Inc..

BioRegio STERN Management GmbH

Second Sight

Sonova

Notable Emerging Companies Mentioned in the Report

iotaMotion, Inc.

Hemideina

TODOC Co., Ltd.

ADVANCED OPTRONICS

Restohearing

Key Target Audience - Organizations and Entities Who Can Benefit by Subscribing This Report

Neuroprosthetics Manufacturers

Neuroprosthetics Suppliers

Output Neural Prosthetics Manufacturers

Input Neural Prosthetics Manufacturers

Deep Brain Stimulation Neuroprosthetics Manufacturers

Vagus Nerve Stimulation Neuroprosthetics Manufacturers

Spinal Cord Stimulation Neuroprosthetics Manufacturers

Sacral Nerve Stimulation Neuroprosthetics Manufacturers

Emerging and Startup Companies in Neuroprosthetics

Different Types of Neuroprosthetics Manufacturing Hubs

Government Ministries and Departments of Healthcare Industry

Healthcare Regulatory Organizations

Healthcare Research Institutes

Importers and Distributors of Neuroprosthetics

Financial Organizations focused on Healthcare Industry

PE and VC Firms focused on Healthcare Industry

Period Captured in the Report

Historical Period: 2017-2021

Forecast Period: 2022E-2028F

Frequently Asked Questions

What is the Study Period of this Market Report?

The Global Neuroprosthetics Market is covered from 2017-2028 in this report, which includes a forecast for the period (2022-2028).

What is the Future Growth Rate of the Global Neuroprosthetics Market?

The global neuroprosthetics market is expected to witness a CAGR of ~12% over the next 6 years.

What are the Key Factors Driving the Global Neuroprosthetics Market?

The rising prevalence of hearing disorders is one of the primary drivers for the growth of the global neuroprosthetics market.

Which is the Largest Application Segment within the Global Neuroprosthetics Market?

The cognitive disorders segment held the largest share of the global neuroprosthetics market in 2021.

Who are the Key Players in the Global Neuroprosthetics Market?

Abbott, Boston Scientific Corporation, Cochlear Ltd, Cyberonics, Inc., LivaNova PLC, Medtronic, NeuroPace, Inc.., BioRegio STERN Management GmbH, Second Sight, Sonova, among others are the major companies operating in Global neuroprosthetics Market.

Table Of Contents

Scope

1. Executive Summary

• 1.1 Highlights of Global Neuroprosthetics Market Historic Growth & Forecast
• 1.2 Highlights of Market Trends, Challenges, and Competition
• 1.3 Highlights of Market Revenue Share by Segments

2. Market Overview and Key Trends Impacting Growth

• 2.1 Global Neuroprosthetics Market Taxonomy
• 2.2 Industry Value Chain
• 2.3 The Ecosystem of Major Entities in the Global Neuroprosthetics Market
• 2.4 Government Regulations & Developments
• 2.5 Key Growth Drivers & Challenges Impacting the Market
• 2.6 COVID-19 Impact on Global Neuroprosthetics Market
• 2.7 Total Neuroprosthetics Market Historic Growth by Segment Type, 2017-2021

2.7.1 By Type

2.7.2 By Technique

2.7.3 By Application

2.7.4 By Region

• 2.8 Total Global Neuroprosthetics Market Historic Growth and Forecast, 2017-2028
• 2.9 Key Takeaways

3. Global - Market Segmentation by Type, Historic Growth, Outlook & Forecasts

• 3.1 Market Definition - Segmentation by Type
• 3.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Type, 2017-2028

3.2.1 Output Neural Prosthetics

3.2.2 Input Neural Prosthetics

• 3.3 Key Takeaways from Market Segmentation by Type

4. Global - Market Segmentation by Technique, Historic Growth, Outlook & Forecasts

• 4.1 Market Definition - Segmentation by Technique
• 4.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Technique, 2017-2028

4.2.1 Deep Brain Stimulation

4.2.2 Vagus Nerve Stimulation

4.2.3 Spinal Cord Stimulation

4.2.4 Sacral Nerve Stimulation

• 4.3 Key Takeaways from Market Segmentation by Technique

5. Global - Market Segmentation by Application, Historic Growth, Outlook & Forecasts

• 5.1 Market Definition - Segmentation by Application
• 5.2 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028

5.2.1 Motor Neural Prosthetics

5.2.2 Physiological Disorders

5.2.3 Cognitive Disorders

• 5.3 Key Takeaways from Market Segmentation by Application

6. Industry / Competition Analysis - Competitive Landscape

• 6.1 Types of Players (Competitors) & Share of Competition
• 6.2 Porter's 5 Forces Analysis of Global Neuroprosthetics Competitors
• 6.3 Key Developments in the Global Neuroprosthetics Sector Impacting Market Growth
• 6.4 Comparison of Leading Competitors within Global Neuroprosthetics Market, 2021
• 6.5 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Type, 2021
• 6.6 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Technique, 2021
• 6.7 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Application, 2021
• 6.8 Comparison of Leading Competitors within Global Neuroprosthetics Market by Coverage of Region, 2021
• 6.9 Key Takeaways from Competitive Landscape

7. Key Competitor Profiles (Company Overview, Product Offerings, and Strengths & Weaknesses Analysis)

• 7.1 Abbott
• 7.2 Boston Scientific Corporation
• 7.3 Cochlear Ltd
• 7.4 Cyberonics, Inc.
• 7.5 LivaNova PLC
• 7.6 Medtronic
• 7.7 NeuroPace, Inc..
• 7.8 BioRegio STERN Management GmbH
• 7.9 Second Sight
• 7.10 Sonova

8. Geographic Analysis & Major Countries Market Historic Growth, Outlook, and Forecasts

• 8.1 Major Countries Comparison of Macroeconomic Factors
• 8.2 Global- Market Revenue Share, Historic Growth, Outlook and Forecasts by Region, 2017-2028
• 8.3 Major Countries Market Analysis, Historic Growth, Outlook & Forecasts
• 8.4 North America - Neuroprosthetics Market Analysis

8.4.1 Major Production and Consumption Hubs in North America

8.4.2 Notable Emerging Neuroprosthetics Companies in North America

8.4.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.4.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.4.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.4.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

USA

Canada

Mexico

• 8.5 Europe - Neuroprosthetics Market Analysis

8.5.1 Major Production and Consumption Hubs in Europe

8.5.2 Notable Emerging Neuroprosthetics Companies in Europe

8.5.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.5.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.5.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.5.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

Germany

UK

France

Spain

Italy

Rest of Europe

• 8.6 Asia Pacific - Neuroprosthetics Market Analysis

8.6.1 Major Production and Consumption Hubs in the Asia Pacific

8.6.2 Notable Emerging Neuroprosthetics Companies in the Asia Pacific

8.6.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.6.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.6.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.6.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028

China

Japan

South Korea

India

Indonesia

Australia

Rest of Asia Pacific

• 8.7 LAMEA - Neuroprosthetics Market Analysis

8.7.1 Major Production and Consumption Hubs in LAMEA

8.7.2 Notable Emerging Neuroprosthetics Companies in LAMEA

8.7.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Type, 2017-2028

8.7.4 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technique, 2017-2028

8.7.5 Market Revenue Share, Historic Growth, Outlook and Forecasts by Application, 2017-2028

8.7.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Sub-Regions, 2017-2028

Latin America

Middle East

Africa

9. Industry Expert's Opinions/Perspectives

• 9.1 Notable Statements/Quotes from Industry Experts and C-Level Executives on Current Status and Future Outlook of the Market

10. Analyst Recommendation

• 10.1 Analyst Recommendations on Identified Major Opportunities and Potential Strategies to Gain from Opportunities

11. Appendix

• 11.1 Research Methodology - Market Size Estimation, Forecast, and Sanity Check Approach
• 11.2 Sample Discussion Guide

Disclaimer